Skip to main content

Table 2 Tumor response, failure Pattern and survival

From: Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

  CRT-alone CRT-AC Total p*
Tumor response, n (%)     0.91
 CR 26 (26.5) 24 (27.0) 50 (26.7)  
 PR 37 (37.8) 30 (33.7) 67 (35.8)  
 SD 31 (31.6) 32 (36.0) 63 (33.7)  
 PD 4 (4.1) 3 (3.3) 7 (3.7)  
Pattern of failure, n (%)     0.399
 Locoregional alone 30(16.1) 35(18.7) 65(34.8)  
 Locoregional and distant 6 (3.2) 2 (1.1) 8(4.3)  
 Distant alone 26 (13.9) 21 (11.2) 47(25.1)  
1, 2,5 y survival rates (%)
 OS 66.7, 39.1, 27.6 75.3, 47.1, 26.9 67.5,41.4, 27.2 0.732
 LFFS 70.4, 57.2, 55.1 69.7, 58.6,49.8 68.7,57.9, 52.4 0.876
 DFFS 74.1, 65.3, 63 83.3, 73, 65.4 78.5, 68.9, 63.9 0.200
  1. *: p value between CRT-alone and CRT-AC